相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea The PIONEER 3 Randomized Clinical Trial
Julio Rosenstock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Peter Gaede et al.
DIABETES THERAPY (2019)
The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia
Samuel J. P. Malkin et al.
ADVANCES IN THERAPY (2019)
Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example
Vanita R. Aroda et al.
DIABETES OBESITY & METABOLISM (2019)
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
Richard Pratley et al.
LANCET (2019)
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Helena W. Rodbard et al.
DIABETES CARE (2019)
Evaluation of the long-term cost-effectiveness of once-weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK
Adie Viljoen et al.
DIABETES OBESITY & METABOLISM (2019)
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
Samuel J. P. Malkin et al.
DIABETES THERAPY (2019)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
Kamlesh Khunti et al.
DIABETES OBESITY & METABOLISM (2018)
Multivariate Prediction Equations for HbA1c, Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modeling
Michael Willis et al.
VALUE IN HEALTH (2017)
Clinical inertia to insulin initiation and intensification in the UK: A focused literature review
Kamlesh Khunti et al.
PRIMARY CARE DIABETES (2017)
Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
K. Khunti et al.
DIABETES OBESITY & METABOLISM (2016)
The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
M. L. Alva et al.
DIABETIC MEDICINE (2015)
Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
Mark D. Danese et al.
VALUE IN HEALTH (2015)
THE COST OF NON-SEVERE HYPOGLYCAEMIA IN EUROPE
B. Chubb et al.
VALUE IN HEALTH (2015)
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Seamus Kent et al.
BMC NEPHROLOGY (2015)
Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries
Jorgen T. Lauridsen et al.
QUALITY OF LIFE RESEARCH (2014)
Validation of the IMS CORE Diabetes Model
Phil McEwan et al.
VALUE IN HEALTH (2014)
Clinical Inertia in People With Type 2 Diabetes A retrospective cohort study of more than 80,000 people
Kamlesh Khunti et al.
DIABETES CARE (2013)
Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries
Marc Evans et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2013)
The Impact of Diabetic Retinopathy and Diabetic Macular Edema on Health-Related Quality of Life in Type 1 and Type 2 Diabetes
Eva K. Fenwick et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
Simon J. Griffin et al.
LANCET (2011)
Costs of managing severe hypoglycaemia in three European countries
Mette Hammer et al.
JOURNAL OF MEDICAL ECONOMICS (2009)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
S. R. Heller et al.
DIABETOLOGIA (2007)
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes
Craig J. Currie et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Evaluation of the association between the EQ-5Dindex (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes
AJ Lee et al.
DIABETIC MEDICINE (2005)
Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data
A Bagust et al.
HEALTH ECONOMICS (2005)
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
AJ Palmer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Validation of the CORE diabetes model against epidemiological and clinical studies
AJ Palmer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis
JB Wasserfallen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)
P Clarke et al.
MEDICAL DECISION MAKING (2002)
分享论文
